COMMUNIQUÉS West-GlobeNewswire

-
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025
30/04/2025 -
iTeos publie les résultats financiers de son premier trimestre 2025 et fait le point sur ses activités
29/04/2025 -
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
29/04/2025 -
Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew
29/04/2025 -
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting
29/04/2025 -
CooperCompanies Announces Release Date for Second Quarter 2025
29/04/2025 -
Certara to Participate in Upcoming Investor Conferences
29/04/2025 -
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
29/04/2025 -
The Ensign Group Reports First Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
29/04/2025 -
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
29/04/2025 -
Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting
29/04/2025 -
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
29/04/2025 -
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
29/04/2025 -
BridgeBio Reports First Quarter 2025 Financial Results and Business Updates
29/04/2025 -
BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025
29/04/2025 -
Artios Pharma Reports Differentiated Clinical Activity in STELLA Phase 1/2a Study for Lead Program ART0380 at the American Association for Cancer Research (AACR) Annual Meeting 2025
29/04/2025 -
Nouscom Presents Positive Final Results from Completed Phase Ib/II Study of Neoantigen Immunotherapy NOUS-209 at AACR 2025, Demonstrating a Highly Potent and Durable Immune Response in Lynch Syndrome Carriers
29/04/2025 -
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
29/04/2025 -
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2024 et du Rapport Annuel Form 20-F 2024
29/04/2025
Pages